Why your hormones are a master schedule, not a side story

Recovery that used to take a night now takes a week. Energy that dipped on Wednesday was reliably back by Friday — until somewhere in the forties, when it stopped making that return journey quite so punctually.

Professor Paul Lee, orthopaedic surgeon, biomedical engineer, and author of Practical Regeneration, has a precise explanation for that shift. He frames hormones not as reproductive background noise but as 'the master schedule for regeneration' — governing bone strength, muscle repair, immune resilience, and how quickly the body rebounds from stress or injury. His metaphor is deliberately ecological: 'If the gut is the soil in our forest, then hormones are the seasons.' They decide not just what the body can build, but when.

This is the core of the Chemistry pillar in his four-pillar framework — one of four interdependent lenses through which Regeneration by Design reads the body. Chemistry covers the internal environment: hormones, nutrition, inflammation, the biochemical signalling that either accelerates or stalls the repair process.

After 40, the schedule quietly changes. Oestrogen, testosterone, and DHEAS — the body's main anabolic counter-weight to cortisol — begin a measurable decline, while cortisol holds relatively steady. The ratio tilts. Repair slows; breakdown holds pace. Which markers track that shift most reliably, and what movement in them actually signals, is where the real clinical intelligence lies.

The baseline panel — markers every adult over 40 needs

Five markers form a sensible starting point for any adult over 40, regardless of sex or symptom profile — a universal layer that catches the most common confounders before the picture grows more specific.

Thyroid-stimulating hormone (TSH) measures how hard the pituitary is working to prompt the thyroid into action. An underactive thyroid produces fatigue, weight gain, low mood, and sluggish recovery — symptoms close enough to hormonal ageing to make the rest of the panel unreliable unless TSH is ruled out first.

HbA1c or HOMA-IR gives a window into blood sugar regulation and insulin sensitivity over weeks rather than a single moment. Declining sex hormones accelerate metabolic drift; a rising HOMA-IR running alongside falling testosterone or oestrogen is an early metabolic warning, not a coincidence, and is often the first modifiable signal to surface in midlife blood work.

Cortisol and DHEAS are most informative read together — this pairing is the centrepiece of any midlife panel. DHEAS drops markedly with age while cortisol holds relatively steady; current evidence suggests the resulting shift towards glucocorticoid dominance correlates with muscle loss, central fat accumulation, immune dysregulation, and reduced healing capacity. A cortisol reading in isolation tells a partial story; the ratio between the two captures the anabolic-catabolic balance that actually governs long-term function.

Vitamin D behaves more like a hormone than a vitamin, regulating immune response, muscle contractile function, and bone metabolism through nuclear receptors. It is frequently low in adults over 40, straightforward to measure, and — crucially — straightforward to correct.

Ferritin tracks iron stores rather than circulating iron levels. Low ferritin impairs oxygen transport and cellular energy production, generating a fatigue nearly indistinguishable from hormonal tiredness, yet it is routinely missed on standard testing. Including it closes one of the most common gaps in midlife health monitoring.

These five markers form the foundation. A curated 32-marker panel — incorporating cardiovascular signals such as ApoB and Lp(a), and the inflammation marker hs-CRP — extends this considerably beyond what routine NHS testing typically covers, shifting the framing from disease screening to an active read on regeneration capacity.

The women's tier — what oestrogen, progesterone, and testosterone are telling you

Oestradiol — the most biologically active form of oestrogen — does far more structural work than its reputation as a 'female sex hormone' implies. In the context of regeneration, it is a maintenance hormone: it preserves bone mineral density, supports cartilage integrity, drives collagen synthesis, and damps down inflammatory signalling in joint tissue. When oestradiol begins to fall in the mid-to-late forties, the downstream effects are not primarily vasomotor (hot flushes are the visible symptom, not the most consequential one) but structural — accelerated bone thinning, reduced capacity for joint repair, and a gradual weakening of the anti-inflammatory buffer that protects tissue from cumulative damage.

FSH and LH are the pituitary's response signals. As ovarian sensitivity to FSH declines, the pituitary produces more of it in an attempt to drive follicular activity — so a rising FSH reading is a meaningful perimenopause indicator. The interpretive caveat is equally important: oestradiol and FSH fluctuate considerably across the day and throughout the menstrual cycle, which means a single blood draw can look reassuring on a day those hormones happen to be peaking. A panel is most useful when read alongside symptoms and, over time, as part of a pattern — not as a one-off verdict.

Progesterone is routinely omitted from standard panels, yet it shapes sleep architecture, mood stability, and how tissue responds to oestrogen. Its decline in perimenopause disrupts the oestrogen-progesterone balance that governs repair signalling — an oversight in screening with real downstream consequences for anyone trying to understand why recovery has shifted.

Testosterone in women declines steadily from the twenties onwards. By the mid-forties it is often meaningfully low, affecting energy, lean muscle maintenance, and libido — yet it rarely appears in routine blood work. Including it gives a more complete picture of the Chemistry shifts governing regenerative capacity across all tissues, not just the reproductive system.

The men's tier — testosterone, SHBG, and the oestrogen men rarely check

The number most men focus on — total testosterone — is only half the picture. A significant portion of circulating testosterone is bound to sex hormone-binding globulin (SHBG) and rendered biologically inactive: it circulates, but cells cannot use it. Free testosterone — the unbound fraction — is what actually governs muscle repair, bone density, energy regulation, and recovery speed.

SHBG rises with age and climbs further as body fat accumulates, two processes that compound each other after 40. Total testosterone may sit within a reference range while free testosterone has quietly fallen below a functional threshold. This is why a Regen PhD-cited cross-sectional study found testosterone deficiency in 55% of symptomatic men aged 40–70 despite no visible change in BMI: the headline figure looked acceptable; the bioavailable fraction did not.

LH and FSH add mechanistic context. When testosterone is low, these pituitary signals indicate where the problem originates — whether the testes are underproducing (primary hypogonadism) or the pituitary drive itself has weakened (secondary). That distinction informs any subsequent strategy and is part of what a well-constructed panel can clarify.

Oestradiol is the marker men most often skip, and most often shouldn't. Adipose tissue converts testosterone to oestrogen through aromatisation; as central fat accumulates after 40, that conversion accelerates, compounding the testosterone deficit while raising oestradiol. Elevated oestradiol in men is associated with further fat accumulation, reduced muscle repair, and joint inflammation — a self-reinforcing cycle that Practical Regeneration identifies as one of the less-discussed consequences of andropause.

The compositional drift — muscle declining, central fat rising — is simultaneously cause and consequence of this hormonal shift. Resistance training addresses both sides: it supports testosterone bioavailability while reducing the adipose mass that drives aromatisation, making it the Physics pillar's direct answer to a Chemistry problem. Some expanded panels also include IGF-1 as a proxy for growth hormone axis activity; evidence for its routine use at this stage remains exploratory, and it is best understood as a contextual addition to the core tier rather than a default marker.

What a result actually means — and what it doesn't

A result that sits 'within range' is reassuring — but only up to a point. Standard reference ranges are built from population data: they describe where the middle 95% of a broad, age-mixed cohort falls, not where any one individual functions best. For someone who has historically lived at the upper end of a range, a reading near the lower boundary may represent a meaningful personal shift that the reference interval itself cannot flag.

This is the core limitation of a one-off panel: it captures where a marker was at the moment of the draw, not where it is heading. Cortisol follows a steep diurnal curve, typically two to three times higher at 8 a.m. than in the afternoon; a difference in draw timing alone can substantially change how a result reads. DHEAS is considerably more stable across the day, which makes it a cleaner longitudinal marker — but even here, direction of travel matters more than any single value.

Pattern is the point. A borderline reading today takes on an entirely different meaning when compared against a reading from six months ago and one from twelve months prior. This is the logic behind Regen365's quarterly biomarker review — not to react to each result in isolation, but to build a longitudinal picture that shows whether markers are holding steady, adapting, or quietly drifting. It is the Time pillar made practical: monitor early enough to see the direction of travel and act before a gradual drift compounds into something harder to reverse.

Symptom experience cannot be overridden by a snapshot number. When a result looks unremarkable but the lived picture clearly isn't, that discrepancy is itself meaningful information — and the most productive place to start a conversation.

Turning the numbers into action

Panels identify the shift. What actually changes it is upstream of the blood draw.

Resistance training is the most evidence-grounded lever available to both men and women after 40 — not because it raises hormone readings directly in every case, but because it supports testosterone bioavailability, maintains oestrogen receptor sensitivity, slows sarcopenia, and reinforces bone density. Three to four sessions a week of compound, progressive resistance work — not light movement but genuine load — create the conditions in which hormonal signalling can function more efficiently. This is the Physics pillar answering a Chemistry signal: mechanical demand and metabolic stress are what make the body worth signalling to in the first place.

Protein and micronutrient density underpin the same logic. Muscle protein synthesis becomes less efficient with age; adequate protein (broadly, 1.6–2 g per kilogram of bodyweight) preserves the raw material for the repair signals hormones are trying to coordinate. Vitamin D, magnesium, and zinc are among the most common deficits in the over-40 cohort, each intersecting with sex hormone function. Managing glycaemic load matters here too: the metabolic drift captured by HbA1c and HOMA-IR is not separate from hormonal change — declining oestrogen and testosterone both impair insulin sensitivity, and the drift compounds each driver.

Sleep and chronic stress are where the Biology pillar connects directly to the panel. Sustained stress keeps cortisol elevated beyond its natural morning peak, suppressing sex hormone production and widening the cortisol-to-DHEAS imbalance. Deep slow-wave sleep is when testosterone is partly restored and growth hormone pulses most strongly — protecting it is not optional when a Chemistry picture is already under pressure.

When shifts are significant or symptoms persist despite lifestyle adjustment, professional consultation is the natural and necessary next step. Hormone support strategies — including HRT where clinically appropriate — require personalised clinical guidance built on longitudinal data, not a self-managed response to a single reading.

Professor Paul Lee's Regeneration by Design makes a structural argument that threads through every pillar: the headline number is rarely the whole signal. What matters — as the SHBG picture illustrates — is the relationship between markers and the direction of travel over time. Practical Regeneration frames this as system thinking made practical: arrange a baseline panel now, set a review date three to six months ahead, and let the trend do the talking.